healthexecwire



  Click here to view this message in a web browser
 
 
2021 Outlook: Biden's Policy Agenda and SDOH Investing
Thursday, December 10, 2020 | 1:00PM - 2:00PM Eastern

 
  • Biden's 2021 policy agenda for health programs
  • Outlook for supplemental benefits and SDOH in 2021
  • Latest on industry arms race on SDOH and what to expect
  • Anticipated CMS policy on SSBCI, SNPs, duals, demonstrations and quality measures

Faculty: John Gorman, Founder and Chairman, Nightingale Partners
 
 

Register Now
 
The COVID-19 pandemic has accelerated a number of key trends throughout the healthcare industry, including Social Determinants of Health initiatives. Even before the pandemic, Medicare Advantage and Medicaid managed care programs began moving aggressively to facilitate insurers and providers offering a range of services and benefits to address Social Determinants of Health, along with Accountable Care Organizations (ACOs) participating in the Medicare Shared Savings Program that share many of the same incentives to address SDOH as insurers do. In addition, the 2017 tax bill contained a provision that created Opportunity Zones (OZs) designed to attract long term investment via tax incentives to address social and economic realities in high poverty communities, that are ideally suited to address SDOH initiatives.

What is the outlook for Medicare Advantage Supplemental Benefits and Social Determinants of Health Initiatives under the Biden administration in 2021 and beyond? This session examines the Biden health policy agenda; the prognosis for Medicare Advantage Supplemental Benefits and Social Determinant of Health Initiatives during the coming year; developments in the SDOH arms race and what CMS policy can be anticipated during 2021 in this arena.
Click here for more details.
 

Please join us on Thursday, December 10, 2020, at 1 PM Eastern as Nightingale Partners' John Gorman explores, in the HealthcareWebSummit event: 2021 Outlook: Biden's Policy Agenda and SDOH Investing. Click here for detailed information or to register or call 209.577.4888.
 
 

  

healthexecwire
www.healthexecwire.com